Studies were performed to identify the receptor that mediates AVP-stimulated phosphoinositide (PI) 
Introduction
In addition to its well established effect to increase cAMP, AVP has also been shown to stimulate phospholipase C (PLC)' and thereby increase cytosolic Ca2' in several renal epithelia. These include the LLC-PK, cell (1-3), the rabbit cortical collecting duct (4), and the rat inner medullary collecting duct (5, 6) . However, the identity ofthe receptor responsible for mediating this effect is controversial. In one study in LLC-PKI cells, the oxytocin receptor has been implicated (1), while in other studies elimination ofthe response to AVP by a V, receptor antagonist suggested that the AVP V, receptor is responsible (2, 3). Similar results supporting a role for the V1 receptor have been 1. Abbreviations used in this paper: IP, inositol phosphate; PI, phosphoinositide; PLC, phospholipase C; RIMCT, rat inner medullary collecting tubule. obtained in freshly isolated rabbit cortical collecting duct principal cells (4). In contrast, in the isolated perfused rat inner medullary collecting duct, a Ca2+ transient was obtained in response to the antidiuretic agonist dDAVP (5), suggesting a role for the V2 receptor. In cultured rat papillary collecting duct cells, the AVP-stimulated increase in cytosolic Ca2+ was inhibited by both an AVP V2 and, to a lesser extent, VI antagonist (6) . This study was therefore undertaken to define exactly which receptor is responsible for mediating AVP-stimulated PLC activity in a homogeneous population of cultured rat inner medullary collecting tubule (RIMCT) cells.
Methods
Cell culture. Cultures of RIMCT cells were prepared as previously described (7, 8) to yield a homogeneous population of nonintercalated cells (9) . For studies on cAMP production, tissue from two rats was used to plate one 24-well Costar dish; for studies on inositol trisphosphate (IP3) production wells were plated at three times this density to obtain uniform confluent cultures.
Determination ofinositolphosphates. At 96 h the Hams F12/Liebovitz L15 medium in which the cells were initially grown was aspirated and the cultures washed twice with sterile PBS. The cells were then fed with inositol-free DMEM supplemented with 3H-myo-2-inositol (5 MCi/well; Amersham Corp., Arlington Heights, IL). Studies were performed after 24 h of labeling, as this time has been demonstrated to be sufficient for incorporation into the phospholipid pool. Media was aspirated from the cells and the cells were washed twice with 500 ,g ofPBS.
The buffer was then aspirated and replaced with 500 ,1 ofPBS without or with the desired agonists and antagonists. The V,, V2, and oxytocin receptor agonists and antagonists employed in this study were all a generous gift from Dr. Maurice Manning (Medical College of Ohio, Toledo). Although not determined in RIMCT cells, the relative potencies of these compounds at the diuretic (V2), vasopressor (V,), and oxytocin receptors in rat tissues is shown in Table I . These values served as guidelines in the selection of test compounds.
Preliminary studies demonstrated that AVP-stimulated IP3 production in RIMCT cells peaks at 10 s. Therefore, all studies were performed for lO s at which time the reaction was terminated by the addition of 500 Mul of ice-cold 20% TCA. The cells were scraped off of the dish and centrifuged at 1,000 g for 10 min. The supernate containing inositol phosphates was washed four times with an equal volume of ether and stored at -20°C until analysis. Inositol phosphates were separated by anion exchange chromatography as described by Berridge et al. ( 15) and previously reported from this laboratory (8, 16) . Results are expressed as cpm of IP3 per well.
Determination of cAMP production. Studies were performed in Krebs-Ringer's buffer, pH 7.4, at 300 mOsm/kg H20 in the presence of 0.5 mM isobutylmethylxanthine to inhibit phosphodiesterase. Incubation with effector solutions and subsequent determinations of cAMP and protein were performed as reported previously (7, 9) . Results are expressed as fmol cAMP/Mg protein.
Previous studies have demonstrated a reciprocal relationship between AVP-stimulated adenylyl cyclase (AC) and PLC activities in RIMCT cells (17) . AVP stimulates AC in dose-dependent fashion; the ensuing increase in cellular cAMP content inhibits PLC (17, 18) . Con- sequently, AVP-stimulated IP3 generation is greatest at concentrations of the peptide at which no cAMP accumulation is observed. In this study, therefore, AVP is employed at 10-'3 M when examining its effect on PLC and at 10-' when examining its effect on AC.
Statistical analysis. In studies on cAMP production, values obtained in triplicate wells are meaned for an "n" ofone; in studies on IP3 production each well is considered an "n" of one. Comparisons between two treatment groups are by the unpaired t test (19) . In all circumstances P < 0.05 is considered significant. Data are presented as mean±SEM.
Results
Effect of V, and V2 receptor agonists. The initial set of experiments examined the response to selective AVP V, or V2 receptor agonists. As seen in Fig. 1 (Table I) does not stimulate IP3 production over the range of 10-'3-10-7 M. In contrast, a response to the V2 receptor agonist VDAVP (Table I) (Fig. 2) . Rather, AVP-stimulated PI hydrolysis is reproduced by a V2 receptor agonist ( Fig. 1) and is inhibited by a V2 receptor antagonist (Fig. 2) Thr'JOVT; 10 M) on basal and AVP-stimulated cAMP accumulation, respectively (n = 3). Neither compound has significant activity at the V2 receptor.
tively modulates activity of the other (17, 18) . Because AVPstimulated PI hydrolysis in LLC-PKI cells has been suggested to occur via occupancy ofthe oxytocin receptor (1), we considered the possibility that this might be the case in RIMCT cells as well and that the effects ofthe V2 receptor agonist and antagonist might be a consequence of cross-reactivity with the oxytocin receptor. We found that oxytocin does indeed stimulate PI hydrolysis in RIMCT cells in dose-dependent fashion (Fig. 3) and that this response is eliminated by the V2 receptor antagonist d(CH2)5D Tyr(Et)VAVP (Fig. 4) , which is known to exhibit cross-reactivity with the oxytocin receptor (Table I) .
Oxytocin has been reported to produce hyponatremia in humans (22, 23) , indicating that it has activity at the V2 receptor. Autoradiographic studies have demonstrated specific oxytocin binding sites in the papillary region ofthe rat kidney (24) and we have found significant stimulation of cAMP production by oxytocin in RIMCT cells (see Results). Therefore, to define whether AVP-stimulated PI hydrolysis is mediated by the V2 or the oxytocin receptor, it was necessary that we employed a highly oxytocin-selective agonist and antagonist neither of which exhibits activity at the V2 receptor (Fig. 5) . The observations that a highly selective oxytocin agonist with no stimulatory activity at the V2 receptor stimulates PLC (Fig. 6) and that a highly selective oxytocin antagonist that does not inhibit AVP-stimulated cAMP accumulation eliminates stimulation of PLC in response to either AVP (Fig. 7) or the V2 agonist VDAVP (Fig. 8) , clearly indicate that AVP-stimulated PI hydrolysis in RIMCT cells is mediated by the oxytocin receptor. Further support for the response to AVP being mediated by the oxytocin receptor derived from the observation that maximal AVP-stimulated IP3 production is not augmented by the addition of I0-' M (Thr4, Gly7) oxytocin (Fig. 9) CS--V .
----o-------a Maneuvers that stimulate AVP release from the posterior pituitary (e.g., hemorrhage, increased plasma osmolality, or the intraventricular administration of carbachol or angiotensin II) result in increased plasma oxytocin levels as well (26) (27) (28) . Whether, in normal physiology, the oxytocin receptor in the mammalian kidney is occupied by oxytocin or by the related neuropeptide, AVP is uncertain. It is clear that occupancy of the receptor results in stimulation ofPLC and hydrolysis ofPI. The role ofAVP-or oxytocin-stimulated PI hydrolysis in modulating the hydroosmotic response to AVP is uncertain. One of the consequences of PI hydrolysis is activation of protein kinase C which inhibits the hydroosmotic response to AVP both pre-and post-cAMP (18, 29, 30) . This suggests that stimulation of PLC by AVP might be involved in turning offthe hydroosmotic response. Alternatively, generation of IP3 with a subsequent increase in cytosolic Ca2l might be necessary for the development of the hydroosmotic responses. Preliminary data reported by Leite et al. support this possibility, as they observed no hydroosmotic response to AVP when cytosolic Ca2+ was chelated with TMB-8 (31) . Lastly, one must consider the possibility that oxytocin receptor-stimulated PI hydrolysis mediates the natriuretic response to oxytocin (32, 33) but plays no role in modulation of the hydroosmotic response to AVP. Further studies will be required to define the physiologic role of AVPstimulated PI hydrolysis that is mediated via the oxytocin receptor.
